As explained by the EPA in “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” the rule establishes streamlined requirements for how healthcare facilities and reverse distributors must manage hazardous waste pharmaceuticals. The regulation prohibits sewering pharmaceuticals, sets clear accumulation and shipment standards, and reduces the regulatory burden for many healthcare operations while improving environmental protection. The rule also reclassifies FDA-approved nicotine replacement therapies so they are no longer considered hazardous waste under the P075 listing.
These standards help facilities maintain compliance by defining proper storage, labeling, container management, and tracking procedures for pharmaceutical waste. By following these requirements, healthcare organizations reduce disposal risks, prevent environmental contamination, and ensure safer handling of hazardous materials throughout their operations. The updated nicotine classification further simplifies disposal for pharmacies and healthcare providers.
Click here to learn more about ERG Environmental’s products and services or here to read the full article.
Article with all rights reserved, courtesy of the U.S. Environmental Protection Agency —https://www.epa.gov